Table of Content

1 Stem Cell Drugs Market Overview
1.1 Product Overview and Scope of Stem Cell Drugs
1.2 Stem Cell Drugs Segment by Type
1.2.1 Global Stem Cell Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Cord Blood-Derived
1.2.3 Adipose-Derived
1.2.4 Bone Marrow-Derived
1.2.5 Others
1.3 Stem Cell Drugs Segment by Application
1.3.1 Stem Cell Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Acute Graft-versus-Host Disease
1.3.3 Crohn’s Disease
1.3.4 Amyotrophic Lateral Sclerosis
1.3.5 Osteoarthritis
1.3.6 Others
1.4 Global Stem Cell Drugs Market Size Estimates and Forecasts
1.4.1 Global Stem Cell Drugs Revenue 2016-2027
1.4.2 Global Stem Cell Drugs Sales 2016-2027
1.4.3 Stem Cell Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Stem Cell Drugs Market Competition by Manufacturers
2.1 Global Stem Cell Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Stem Cell Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Stem Cell Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Stem Cell Drugs Manufacturing Sites, Area Served, Product Type
2.5 Stem Cell Drugs Market Competitive Situation and Trends
2.5.1 Stem Cell Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Stem Cell Drugs Players Market Share by Revenue
2.5.3 Global Stem Cell Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Stem Cell Drugs Retrospective Market Scenario by Region
3.1 Global Stem Cell Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Stem Cell Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Stem Cell Drugs Market Facts & Figures by Country
3.3.1 North America Stem Cell Drugs Sales by Country
3.3.2 North America Stem Cell Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Stem Cell Drugs Market Facts & Figures by Country
3.4.1 Europe Stem Cell Drugs Sales by Country
3.4.2 Europe Stem Cell Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Stem Cell Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Stem Cell Drugs Sales by Region
3.5.2 Asia Pacific Stem Cell Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Stem Cell Drugs Market Facts & Figures by Country
3.6.1 Latin America Stem Cell Drugs Sales by Country
3.6.2 Latin America Stem Cell Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Stem Cell Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Stem Cell Drugs Sales by Country
3.7.2 Middle East and Africa Stem Cell Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Stem Cell Drugs Historic Market Analysis by Type
4.1 Global Stem Cell Drugs Sales Market Share by Type (2016-2021)
4.2 Global Stem Cell Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Stem Cell Drugs Price by Type (2016-2021)

5 Global Stem Cell Drugs Historic Market Analysis by Application
5.1 Global Stem Cell Drugs Sales Market Share by Application (2016-2021)
5.2 Global Stem Cell Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Stem Cell Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 JCR Pharmaceuticals Co., Ltd
6.1.1 JCR Pharmaceuticals Co., Ltd Corporation Information
6.1.2 JCR Pharmaceuticals Co., Ltd Description and Business Overview
6.1.3 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 JCR Pharmaceuticals Co., Ltd Product Portfolio
6.1.5 JCR Pharmaceuticals Co., Ltd Recent Developments/Updates
6.2 CORESTEM, Inc
6.2.1 CORESTEM, Inc Corporation Information
6.2.2 CORESTEM, Inc Description and Business Overview
6.2.3 CORESTEM, Inc Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 CORESTEM, Inc Product Portfolio
6.2.5 CORESTEM, Inc Recent Developments/Updates
6.3 Pharmicell Co., Ltd
6.3.1 Pharmicell Co., Ltd Corporation Information
6.3.2 Pharmicell Co., Ltd Description and Business Overview
6.3.3 Pharmicell Co., Ltd Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pharmicell Co., Ltd Product Portfolio
6.3.5 Pharmicell Co., Ltd Recent Developments/Updates
6.4 Anterogen
6.4.1 Anterogen Corporation Information
6.4.2 Anterogen Description and Business Overview
6.4.3 Anterogen Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Anterogen Product Portfolio
6.4.5 Anterogen Recent Developments/Updates
6.5 Chiesi Pharmaceuticals
6.5.1 Chiesi Pharmaceuticals Corporation Information
6.5.2 Chiesi Pharmaceuticals Description and Business Overview
6.5.3 Chiesi Pharmaceuticals Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Chiesi Pharmaceuticals Product Portfolio
6.5.5 Chiesi Pharmaceuticals Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Corporation Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Takeda Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 New York Blood Center
6.6.1 New York Blood Center Corporation Information
6.6.2 New York Blood Center Description and Business Overview
6.6.3 New York Blood Center Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 New York Blood Center Product Portfolio
6.7.5 New York Blood Center Recent Developments/Updates
6.8 MEDIPOST
6.8.1 MEDIPOST Corporation Information
6.8.2 MEDIPOST Description and Business Overview
6.8.3 MEDIPOST Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 MEDIPOST Product Portfolio
6.8.5 MEDIPOST Recent Developments/Updates

7 Stem Cell Drugs Manufacturing Cost Analysis
7.1 Stem Cell Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Stem Cell Drugs
7.4 Stem Cell Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Stem Cell Drugs Distributors List
8.3 Stem Cell Drugs Customers

9 Stem Cell Drugs Market Dynamics
9.1 Stem Cell Drugs Industry Trends
9.2 Stem Cell Drugs Growth Drivers
9.3 Stem Cell Drugs Market Challenges
9.4 Stem Cell Drugs Market Restraints

10 Global Market Forecast
10.1 Stem Cell Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Stem Cell Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Stem Cell Drugs by Type (2022-2027)
10.2 Stem Cell Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Stem Cell Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Stem Cell Drugs by Application (2022-2027)
10.3 Stem Cell Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Stem Cell Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Stem Cell Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Stem Cell Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Stem Cell Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Stem Cell Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Stem Cell Drugs Covered in This Study
Table 5. Global Stem Cell Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Stem Cell Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Stem Cell Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Stem Cell Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Stem Cell Drugs Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Stem Cell Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Stem Cell Drugs Product Type
Table 12. Global Stem Cell Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Stem Cell Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Stem Cell Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Stem Cell Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Stem Cell Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Stem Cell Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Stem Cell Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Stem Cell Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Stem Cell Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Stem Cell Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Stem Cell Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Stem Cell Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Stem Cell Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Stem Cell Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Stem Cell Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Stem Cell Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Stem Cell Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Stem Cell Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Stem Cell Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Stem Cell Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Stem Cell Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Stem Cell Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Stem Cell Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Stem Cell Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Stem Cell Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Stem Cell Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Stem Cell Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Stem Cell Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Stem Cell Drugs Revenue Share by Type (2016-2021)
Table 42. Global Stem Cell Drugs Price (US$/Unit) by Type (2016-2021)
Table 43. Global Stem Cell Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Stem Cell Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Stem Cell Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Stem Cell Drugs Revenue Share by Application (2016-2021)
Table 47. Global Stem Cell Drugs Price (US$/Unit) by Application (2016-2021)
Table 48. JCR Pharmaceuticals Co., Ltd Corporation Information
Table 49. JCR Pharmaceuticals Co., Ltd Description and Business Overview
Table 50. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Product
Table 52. JCR Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 53. CORESTEM, Inc Corporation Information
Table 54. CORESTEM, Inc Description and Business Overview
Table 55. CORESTEM, Inc Stem Cell Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. CORESTEM, Inc Stem Cell Drugs Product
Table 57. CORESTEM, Inc Recent Developments/Updates
Table 58. Pharmicell Co., Ltd Corporation Information
Table 59. Pharmicell Co., Ltd Description and Business Overview
Table 60. Pharmicell Co., Ltd Stem Cell Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Pharmicell Co., Ltd Stem Cell Drugs Product
Table 62. Pharmicell Co., Ltd Recent Developments/Updates
Table 63. Anterogen Corporation Information
Table 64. Anterogen Description and Business Overview
Table 65. Anterogen Stem Cell Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Anterogen Stem Cell Drugs Product
Table 67. Anterogen Recent Developments/Updates
Table 68. Chiesi Pharmaceuticals Corporation Information
Table 69. Chiesi Pharmaceuticals Description and Business Overview
Table 70. Chiesi Pharmaceuticals Stem Cell Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Chiesi Pharmaceuticals Stem Cell Drugs Product
Table 72. Chiesi Pharmaceuticals Recent Developments/Updates
Table 73. Takeda Corporation Information
Table 74. Takeda Description and Business Overview
Table 75. Takeda Stem Cell Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Takeda Stem Cell Drugs Product
Table 77. Takeda Recent Developments/Updates
Table 78. New York Blood Center Corporation Information
Table 79. New York Blood Center Description and Business Overview
Table 80. New York Blood Center Stem Cell Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. New York Blood Center Stem Cell Drugs Product
Table 82. New York Blood Center Recent Developments/Updates
Table 83. MEDIPOST Corporation Information
Table 84. MEDIPOST Description and Business Overview
Table 85. MEDIPOST Stem Cell Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. MEDIPOST Stem Cell Drugs Product
Table 87. MEDIPOST Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Stem Cell Drugs Distributors List
Table 91. Stem Cell Drugs Customers List
Table 92. Stem Cell Drugs Market Trends
Table 93. Stem Cell Drugs Growth Drivers
Table 94. Stem Cell Drugs Market Restraints
Table 95. Global Stem Cell Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Stem Cell Drugs Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Stem Cell Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Stem Cell Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Stem Cell Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Stem Cell Drugs Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Stem Cell Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Stem Cell Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Stem Cell Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Stem Cell Drugs Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Stem Cell Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Stem Cell Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Stem Cell Drugs
Figure 2. Global Stem Cell Drugs Market Share by Type in 2020 & 2027
Figure 3. Cord Blood-Derived Product Picture
Figure 4. Adipose-Derived Product Picture
Figure 5. Bone Marrow-Derived Product Picture
Figure 6. Others Product Picture
Figure 7. Global Stem Cell Drugs Market Share by Application in 2020 & 2027
Figure 8. Acute Graft-versus-Host Disease
Figure 9. Crohn’s Disease
Figure 10. Amyotrophic Lateral Sclerosis
Figure 11. Osteoarthritis
Figure 12. Others
Figure 13. Global Stem Cell Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Stem Cell Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global Stem Cell Drugs Sales 2016-2027 (K Units)
Figure 16. Global Stem Cell Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Stem Cell Drugs Sales Share by Manufacturers in 2020
Figure 18. Global Stem Cell Drugs Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Stem Cell Drugs Players: Market Share by Revenue in 2020
Figure 20. Stem Cell Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Stem Cell Drugs Sales Market Share by Region (2016-2021)
Figure 22. Global Stem Cell Drugs Sales Market Share by Region in 2020
Figure 23. Global Stem Cell Drugs Revenue Market Share by Region (2016-2021)
Figure 24. Global Stem Cell Drugs Revenue Market Share by Region in 2020
Figure 25. U.S. Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Stem Cell Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Stem Cell Drugs by Type (2016-2021)
Figure 50. Sales Market Share of Stem Cell Drugs by Application (2016-2021)
Figure 51. Sales Market Share of Stem Cell Drugs by Application in 2020
Figure 52. Revenue Share of Stem Cell Drugs by Application (2016-2021)
Figure 53. Revenue Share of Stem Cell Drugs by Application in 2020
Figure 54. Manufacturing Cost Structure of Stem Cell Drugs
Figure 55. Manufacturing Process Analysis of Stem Cell Drugs
Figure 56. Stem Cell Drugs Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed